Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes

Author： Pascual Gabriel   Ricote Mercedes   Hevener Andrea L  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.11, 2007-11, pp. : 1503-1520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peroxisome proliferator-activated receptor-γ: therapeutic target for diseases beyond diabetes: quo vadis?

By Pershadsingh Harrihar A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 215-228

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis

By Malhotra Samir   Bansal Dipika   Shafiq Nusrat   Pandhi Promila   Kumar Bhushan  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1455-1461

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases

By Bedu Elodie   Wahli Walter   Desvergne Béatrice  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite

Existing and potential therapeutic approaches targeting peroxisome proliferator-activated receptors in the management of Type 2 diabetes

By Stefanski Dr Adam   Majkowska Liliana  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1713-1733

Informa Healthcare

Access to resources Recommend Favorite

Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome

By Miller Anne R   Etgen Garret J  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1489-1500

Informa Healthcare

Access to resources Recommend Favorite